Owlet has launched two medical devices, Dream Sock and BabySat, designed to provide caregivers with real-time health insights for infants.

The two new at-home infant monitors have recently received approval from the FDA.

The Dream Sock and BabySat devices aim to alleviate stress on parents by accurately tracking and displaying vital signs, alerting them to take action when necessary.

Dream Sock has been available without a prescription since its De Novo clearance by the FDA in November 2023.

Claimed to be the first and only of its kind, the device will monitor and show the baby’s live health readings, including pulse rate and oxygen saturation level.

The readings will be provided to caregivers through the Owlet Dream App.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Owlet paediatric cardiologist and senior director of medical affairs Dr Alisa Niksch said: “Dream Sock is a breakthrough product for the industry and expands our medical-grade monitoring technology to all consumers.

“This device will equip parents of otherwise healthy babies with the real-time data they need to make informed care decisions for their infants. Owlet is dedicated to advancing the capabilities of Dream Sock to enhance care for infants in the home.”

Intended for infants with acute or chronic medical conditions, the BabySat device offers hospital-grade accuracy and is available by prescription only.

It allows healthcare providers to set custom alarms for an infant’s oxygen saturation and pulse rate.

Owlet Healthcare senior vice-president and general manager Jim Fidacaro said: “The launch of BabySat is a huge accomplishment for both parents and providers to enhance care coordination outside of the hospital.

“It extends medical-grade, personalised infant care to the home environment, and with oversight from a physician, parents of babies with health conditions can feel more in control of their little one’s well-being.”